Literature DB >> 11123036

T cells in the pathogenesis of systemic lupus erythematosus: potential roles of CD154-CD40 interactions and costimulatory molecules.

M J Yellin1, U Thienel.   

Abstract

CD154 is an activation-induced CD4+ T cell surface molecule that interacts with CD40 on antigen-presenting cells (APC) and upregulates the key costimulatory molecules, CD80 and CD86. Bidirectional intercellular signaling mediated by CD40 ligation and CD80/CD86 interactions with counter-receptors on T cells play central roles in regulating the survival and outgrowth of pathogenic autoreactive T cells and B cells in systemic lupus erythematosus (SLE). CD40 is also expressed on a variety of other cells, including endothelial cells and renal tubule epithelial cells. CD154 activation of APCs, endothelial cells, and renal tubular epithelial cells have proinflammatory or procoagulant effects that may contribute to the pathogenesis of lupus. This review will focus on the immunobiology of CD154-CD40 interactions and the costimulatory functions of CD80 and CD86. The experimental evidence suggesting roles for these molecules in the immunopathogenesis of SLE will be reviewed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123036     DOI: 10.1007/s11926-996-0065-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  69 in total

1.  The CD40 ligand expressed by human B cells costimulates B cell responses.

Authors:  A C Grammer; M C Bergman; Y Miura; K Fujita; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts.

Authors:  Y Zhang; H J Cao; B Graf; H Meekins; T J Smith; R P Phipps
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

Review 4.  How B and T cells talk to each other.

Authors:  E A Clark; J A Ledbetter
Journal:  Nature       Date:  1994-02-03       Impact factor: 49.962

5.  Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.

Authors:  F Mach; U Schönbeck; G K Sukhova; T Bourcier; J Y Bonnefoy; J S Pober; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

6.  T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.

Authors:  M J Yellin; J Sinning; L R Covey; W Sherman; J J Lee; E Glickman-Nir; K C Sippel; J Rogers; A M Cleary; M Parker
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

7.  Defective antigen-presenting cell function in patients with systemic lupus erythematosus.

Authors:  G C Tsokos; B Kovacs; P P Sfikakis; S Theocharis; S Vogelgesang; C S Via
Journal:  Arthritis Rheum       Date:  1996-04

8.  Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.

Authors:  A M Cleary; S M Fortune; M J Yellin; L Chess; S Lederman
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

9.  Treatment of murine lupus with CTLA4Ig.

Authors:  B K Finck; P S Linsley; D Wofsy
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

10.  Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.

Authors:  A Nakajima; M Azuma; S Kodera; S Nuriya; A Terashi; M Abe; S Hirose; T Shirai; H Yagita; K Okumura
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

View more
  6 in total

1.  Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway.

Authors:  J D Fayen
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

2.  TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus.

Authors:  Lie Mao; Hongyan Hou; Shiji Wu; Yu Zhou; Juan Wang; Jing Yu; Xiaohui Wu; Yanfang Lu; Liyan Mao; Munyemana Jean Bosco; Feng Wang; Ziyong Sun
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

3.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

Review 4.  CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Nada Alaaeddine; Ghada S Hassan; Daniel Yacoub; Walid Mourad
Journal:  Clin Dev Immunol       Date:  2011-10-24

Review 5.  Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.

Authors:  Anselm Mak; Nien Yee Kow
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

6.  Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling.

Authors:  Shu-Fen Wu; Chia-Bin Chang; Jui-Mei Hsu; Ming-Chi Lu; Ning-Sheng Lai; Chin Li; Chien-Hsueh Tung
Journal:  Arthritis Res Ther       Date:  2017-08-09       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.